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Labyrinthine involvement in Behc¸et’s syndrome
L. Pollak, M.D., L. M. Luxon, B.Sc., F.R.C.P., D. O. Haskard, D.M., F.R.C.P.*
Abstract
We report the neuro-otological ndings in 26 consecutive patients with denite and probable Behc¸et’s
syndrome unselected for audiovestibular complaints. Auditory and/or vestibular abnormalities were
found in 19 (73 per cent) patients, with auditory involvement in 14 (54 per cent) and vestibular in 10 (38.5
per cent) of patients. Peripheral involvement was more common than central involvement for both
auditory and vestibular lesions. Bilateral cochlear hearing impairment was the most common audiological
nding, whereas unilateral peripheral dysfunction was the prevailing vestibular abnormality. No
correlation has been found between audiovestibular lesions and other organ lesions, disease duration
or age or sex of the patients. Moreover, there was a lack of interdependence between cochlear and
vestibular labyrinthine lesions. We conclude that a full neuro-otological assessment in patients under
investigation for Behc¸et’s syndrome may reveal labyrinth involvement in a substantial proportion of
patients. In view of the absence of a specic diagnostic test for Behc¸et’s syndrome, audiovestibular lesions
may provide further diagnostic support for this disorder.
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Introduction
Behc¸et’s syndrome is a systemic relapsing inamma-
tory disease of unknown aetiology. It is common in
the Far East and eastern Mediterranean (prevalence
1:1000), but less common in Northern Europe and
the United States.1–6 The disease affects both males
and females, usually in their third or fourth decade.3
The clinical presentation of Behc¸et’s syndrome is
heterogeneous, with variable involvement of many
organs. Since there is no accepted diagnostic test,
recognition of the disease relies on identication of
its characteristic clinical features. The International
Study Group1,2 have recommended that recurrent
oral ulceration be required for denite diagnosis,
together with two of the four following features –
genital ulcers, eye lesions, skin lesions and skin
hypersensitivity reaction (pathergy). The presence of
other signs such as arthritis, gastrointestinal, vascular
or central nervous system involvement (‘minor
criteria’) may support the diagnosis, but they do
not occur with sufcient frequency to be included in
a set of diagnostic criteria.1,2
Inner ear involvement in patients with Behc¸et’s
syndrome has been reported, but while extensive
audiological studies have been performed, vestibular
function has not been studied in detail.7–13We report
the clinical and neuro-otological ndings in a series
of 26 consecutive patients with Behc¸et’s syndrome
and the relationship of these ndings to other clinical
manifestations.
Methods
Patients
Twenty-six consecutive patients with Behc¸et’s syn-
drome, unselected for audiovestibular complaints,
were referred from the Rheumatology Unit of
Hammersmith Hospital, London, for neuro-otologi-
cal assessment. Detailed information was obtained
regarding present complaints, past medical history
(with particular reference to ear, eye and neurolo-
gical disease), family and drug history. Patients with
a history of cranial trauma, use of ototoxic drugs,
otological or neurological disease unrelated to
Behc¸et’s syndrome, or patients with metabolic
conditions associated with inner ear damage, were
excluded from the study.
All patients underwent a clinical neuro-otological
examination, which included a Romberg test, gait
testing with and without eye closure, and an eye
movement examination (assessment of convergence,
smooth pursuit, saccades, doll’s head manoeuvre and
optokinetic nystagmus in response to a small
motorized drum which we use for clinical examina-
tion and an evaluation of spontaneous nystagmus in
primary gaze and during gaze deviation to 30 8 in
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each direction in the horizontal and vertical planes,
as well as positional nystagmus during the Hallpike
positional test.14
Detailed audiometric and vestibular testing were
conducted.
Audiometric methods
Pure-tone audiometry. Pure-tone audiometry (PTA)
was carried out at 0.25, 0.5, 1, 2, 4 and 8 kHz using a
GSI 16 diagnostic audiometer. Asymmetry was
dened by a difference of >15 dB on at least two
frequencies, or >20 dB on a single frequency. A
hearing loss of 21–40 dB was dened as mild,
41–80 dB as moderate and above 80 dB as severe.16
Acoustic reex thresholds. Ipsilateral and contralat-
eral acoustic reex thresholds (ARTs) were obtained
using a GSI 33 oto-admittance-meter in 5-dB steps
up to a maximum output of 110 dB HL at 0.5 and
1 kHz, 105 dB at 2 kHz and 100 dB at 4 kHz
ipsilaterally, and up to 120 dB HL at 0.5, 1 and
2 kHz and 115 dB at 4 kHz contralaterally. ART
upper limits not exceeding 105 dB HL at up to two
adjacent frequencies and/or an interaural difference
not exceeding 10 dB at no more than two adjacent
frequencies were considered normal in patients with
cochlear hearing loss less than 60 dB.17
Brainstem auditory evoked potentials. Brainstem
auditory evoked potentials (BAEPs) were per-
formed on Medelec MSL 10 Sensor, using 100- m s
click stimuli of up to 100 dB HL stimulus intensity
delivered through TDH 49 headphones. Two
averages of 1024 sweeps were recorded and the
reproducible components of each trace were identi-
ed.18 The normal values in our laboratory are:
I–III<2.4 msec, III–V<2.2 msec and I–V<4.4 msec,
asymmetry <0.2 msec.
Transient evoked otoacoustic emissions. Transient
evoked otoacoustic emissions (TOAEs) were
recorded using the Otodynamics ILO 88 analyser
with a ‘non-linear’ click stimulus of 80 m sec electrical
duration, presented at a repetition rate of 50 Hz and
an intensity of 80 6 4 dB SPL. A foam tip was used to
seal the probe in the external canal and recordings
were taken only if a stable stimulus was present. Each
response consisted of an average of 260 sweeps
obtained with a preset artefact rejection facility.
Spectral analysis and amplitude measurements were
calculated automatically by the system. Three TOAE
parameters (total response energy, total noise energy
and interwave correlation) were analysed. A
response was considered normal or present if the
total response energy was signicantly greater (3 dB)
than the noise level, and if the correlation (reprodu-
cibility) was greater than 50 per cent.19
Vestibular assessment
Eye movements were recorded by direct current
electronystagmography using a standard test bat-
tery.20 Surface electrodes were attached at the inner
and outer canthi to record horizontal eye move-
ments. Calibration was performed at the beginning
and at the end of the testing. The eye movements
were recorded on polygraph paper.
Horizontal saccades were tested by asking the
patient to look between two xation points, posi-
tioned straight ahead and at 30 8 to the right and left,
while sitting with the head xed. A consistent
amplitude step of <80 per cent of the target step or
velocity of <300 8 /sec was deemed abnormal.
Smooth pursuit was generated by a smoothly
moving sinusoidal laser target, while the patient
was asked to track it. The amplitude of the target
was set at 30 8 to right and left of centre and the
frequency of the target oscillation was 0.2, 0.3 and
0.4 Hz. A gain of <70 per cent was considered
abnormal.
Optokinetic nystagmus (OKN) was induced by
rotating a large curtain with white vertical stripes
spaced at 15.6 8 intervals. The curtain was rotated at
constant velocity of 40 8 /sec for 20 sec, alternately to
right and left around the patient. A gain of <60 per
cent was considered abnormal. The full eld large
curtain is part of the vestibular investigation which
allows for quantitative optokinetic stimulation and
EOG recording.
The vestibuloocular reex (VOR) was tested by
both sinusoidal oscillation (0.2 Hz, peak velocity
30 8 /sec) and by step acceleration stimulus to right
and left (<1 sec to a constant velocity of 60 8 /sec),
while the subject was sitting in the dark with eyes
open. The peak velocity of the slow component of
the induced nystagmus was measured and a gain of
<40 per cent or an asymmetry of >25 per cent were
deemed abnormal.
Vestibuloocular reex suppression (VORS) was
tested during sinusoidal rotation, as above, while the
patient xated at a small light attached to the chair
directly in front of him. Break through nystagmus,
with a slow component velocity to stimulus velocity
ratio exceeding 0.05, was deemed abnormal.
Spontaneous or gaze evoked nystagmus, in the
presence and absence of optic xation, was recorded
by asking the patient to xate on LEDs directly
ahead and 30 8 to the right and left, respectively, and
maintain their direction of gaze, after the light was
turned off. More than 5 beats of nystagmus of 4 8 /sec
was deemed abnormal.
The bithermal caloric testing was performed by
direct observation of the induced nystagmus
response.21 The duration of the nystagmus was
measured with visual xation in the light and without
xation in a dark room using Frenzel’s glasses. Canal
paresis or directional preponderance were calculated
according to Jongkees formula.22 Values greater
than eight per cent for canal paresis and 12 per cent
for directional preponderance were deemed abnor-
mal.23 Either of these patterns, in the absence of any
central oculomotor abnormality and with a normal
vestibular suppression, was considered to indicate
peripheral vestibular pathology.
Unidirectional horizontal nystagmus, obeying
Alexander’s law and suppressed by optic xation,
was dened as nystagmus of the peripheral type.
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Direction changing vertical or horizontal nystagmus,
uninhibited by vision, was dened as nystagmus of
central type. Central oculomotor abnormalities
comprised unilateral or bilateral abnormalities of
OKN, smooth pursuit or VORS.20
Data analysis
The eye movement records were analysed for peak
velocities of OKN, VOR and smooth pursuit to both
right and left. The gain of each of these parameters
was calculated. Normal values in our laboratory can
be seen at the bottom of Table III.
Statistical analysis
A chi-squared test was performed to check whether
the occurrence of audiovestibular involvement was
associated with individual organ involvement. In
addition, the method of linear regression was applied
to look for correlation between the patients’ age,
disease duration and audiovestibular involvement.24
Results
Clinical characteristics
The clinical characteristics of the patients with
Behc¸et’s syndrome are summarized in Table I.
There were nine men and 17 women of mean age
38.2 years (SD 11.5, range 16–62). the mean disease
duration was 13.8 years (SD 8.9, range 3–36). The
diagnosis of Behc¸et’s syndrome was considered
‘denite’ in 20 (77 per cent) of patients, based on
the ISG criteria. In the remaining six patients the
diagnosis was considered ‘probable’, based upon the
presence of two of the manifestations listed under
the ISG criteria and a consistent overall clinical
picture.
Oral ulcers were present in all patients. Present or
past genital ulcers were noted in 21 (81 per cent) of
patients. Sixteen (61.5 per cent) of patients had eye
involvement (iridocyclitis, hypopyon or chorio-
retinitis) at some stage of the disease. Of the 18
(69 per cent) of patients with skin lesions (erythema
nodosum, pustules), ve had demonstrated a positive
pathergy test. Central nervous system involvement,
in the form of meningoencephalitis, brainstem
syndrome, pseudotumour cerebri and/or white
matter lesions on brain MRI, was present in 11 (42
per cent). There was a history of vascular occlusion
and/or thrombophlebitis in seven (27 per cent)
patients, arthritis in six (23 per cent), and gastro-
intestinal involvement in three (11 per cent) patients.
Patient 19 had also a history of epididymitis. Head-
aches were common (27 per cent) even in the
absence of objective CNS involvement.
TABLE I
clinical manifestations of patients with behc¸et’s syndrome in our series
‘Major signs’ ‘Minor signs’
Patient
No.
Age
(years) Sex
Disease
Duration
(years)
Oral
Ulcers
Genital
Ulcers
*a
Eye
lesions
*b
Skin
lesions Pathergy Arthritis
*c
GIT
inv.
*d
Vascu lar
Inv.
*e
CNS
Inv.
Audio
and/or
ve stib u la r
Inv.
Behc¸et’s
diagnosis
1 46 M 15 1 1 2 2 2 2 2 1 1 1 Probable
2 36 F 11 1 1 1 1 2 2 2 1 2 2 Denite
3 51 F 4 1 2 1 1 2 1 2 2 1 1 Denite
4 35 F 20 1 1 2 2 2 2 2 – 1 1 Probable
5 38 M 30 1 1 1 1 1 1 1 2 2 1 Denite
6 41 F 11 1 1 1 1 2 2 2 2 2 1 Denite
7 47 F 30 1 1 1 2 2 2 2 2 2 1 Denite
8 16 M 4 1 1 1 1 2 1 2 2 1 1 Denite
9 37 M 10 1 2 2 1 2 2 2 2 2 2 Probable
10 56 M 14 1 1 2 1 2 2 2 2 2 2 Denite
11 28 F 18 1 2 1 2 2 2 2 2 2 1 Probable
12 46 F 9 1 1 1 1 2 1 2 2 1 1 Denite
13 62 M 13 1 1 1 2 2 2 2 2 1 1 Denite
14 58 F 36 1 1 2 1 2 2 2 1 1 1 Denite
15 32 F 14 1 1 1 1 1 2 2 1 1 1 Denite
16 34 F 5 1 1 2 1 2 2 2 2 2 1 Denite
17 23 M 15 1 1 2 2 2 1 2 2 1 2 Probable
18 29 F 3 1 1 1 1 2 2 2 2 2 2 Denite
19 36 F 23 1 1 1 1 1 2 1 2 2 2 Denite
20 33 M 4 1 1 2 1 1 2 2 2 2 2 Denite
21 22 F 3 1 1 2 1 1 2 1 2 2 1 Denite
22 30 F 14 1 1 1 1 2 2 2 2 2 1 Denite
23 33 M 10 1 2 1 1 2 2 2 1 2 1 Denite
24 46 F 5 1 1 1 2 2 2 2 1 2 1 Denite
25 28 F 20 1 1 2 2 2 2 2 2 1 1 Probable
26 49 F 18 1 2 1 1 2 1 2 1 1 1 Denite
Total 26 21 16 18 5 6 3 7 11 19 Denite=20
% 100 81 61.5 69 19 23 11 27 42 73 77
inv; involvement; 1 , present; 2 , absent; F, female; M, male. *a Iridocyclitis, hypopyon or chorioretinitis; *b Erythema nodosum,
pustular lesions; *c Gastrointestinal symptoms and/or ulcerative colitis; *d Vascular occlusions or thrombophlebitis;
*e Meningoencephalitis, brainstem syndrome, pseudotumour cerebri and/or presence of white matter lesions on MRI.
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Nineteen (73 per cent) patients had detectable
auditory and/or vestibular involvement. No statistical
relationship was found between any other system
involvement and audiovestibular involvement, nor
between the auditory and vestibular lesions
(p>0.097). In addition, there was no correlation
between the patients’ age, disease duration and
audiovestibular involvement.
Audiological ndings
The audiological ndings are summarized in Table
II. Sixteen (61.5 per cent) patients reported auditory
symptoms, such as hearing impairment, tinnitus,
aural fullness or hearing distortion, and in three
the auditory symptom was a major complaint. In 12
of these 16 patients and in a further two asympto-
matic patients, abnormalities were found on audio-
logical testing.
Audiometric evaluation showed sensorineural
hearing loss (SNHL) in 11 patients: in three patients
the SNHL was mild, in six moderate and two
patients severe. In three patients, the hearing loss
was asymmetric. No typical audiometric congura-
tion was detected; low frequency, high frequency,
and plateau conguration were all observed, but
bilateral involvement was more commonly observed
than unilateral involvement.
The ART measurements were elevated or absent
in ve cases and in two cases, in conjunction with
other audiological tests, suggested the presence of a
retrocochlear lesion (patients 7 and 8).
BAEP recordings revealed a central auditory
lesion in two patients, with a history of CNS
involvement (focal neurological signs in patient 3
and aseptic encephalitis in patient 8). Prolonged
latencies or absent waves V were recorded. Patient 8
TABLE II
audiological assessment of patients with behc¸et’s syndrome
Patient
No.
Symptoms
*a
PTA
*b
ART
*c
BAEP
*d
OAE
*e Conclusions
1 1 mild BiSNHL (hf a) N N Bilateral cochlear lesion
2 2 N N N Normal
3 2 N N _V lt N Central auditory involvement
4 1 N N N Normal
5 2 N N N
bilat
N Normal
6 1 1 1 severe BiSNHL absent absent I Bilateral cochlear lesion
7 2 N all elevated N absent rt Right cochlear and
retrocochlear lesion
8 1 1 1 mild/mod BiSNHL (hf a)
(poor speech discrimination)
absent or elevated bilat
absent V
Bilateral asymmetric
retrocochlear lesions
9 1 N na N Normal
10 2 N N N Normal
11 2 N N N Normal
12 1 bilat mild SNHL a N N Bilateral asymmetric cochlear
lesion
13 1 1 bilat moderate SNHL (hf) N N Bilateral cochlear lesion
14 1 moderate lt SNHL (lf) N N Unilateral cochlear lesion
15 1 N N N Normal
16 1 moderate lt CHL absent or elevated N Unilateral conductive hearing
impairment
17 2 N N N N Normal
18 2 N N N Normal
19 2 N N N Normal
20 2 N
bilat moderate SNHL lf,
N N N Normal
21 1 1 1 bilat severe SNHL hf a N N absent lt Asymmetric cochlear lesion
22 1 N N N abno rm a l b ila t Bilateral cochlear lesion
23 1 1 bilat moderate SNHL N N absent Bilateral cochlear lesion
24 1 1 bilat moderate SNHL
hf & mild lt CHL
absent or elevated na Bilateral cochlear lesion,
unilateral conductive hearing
loss
25 1 N N N N Normal
26 1 bilat mild SNHL N N absent Bilateral cochlear lesion
*a 1 mild, 1 1 moderate, 1 1 1 severe, 2 absent.
*b PTA = pure tone audiometry, SNHL = sensorineural hearing loss, CHL = conductive hearing loss, mild = 21–40 dB, moderate
= 41–80 dB, severe = >80 dB, a = asymmetric ( > 10 dB difference between ears at least 2 frequencies), hf = high frequencies
(3000–8000 Hz), lf = low frequencies (250, 500 Hz).
*c ART = acoustic reex thresholds, N = normal (for cochlear HL < 60 dB SRT < 105 dB at 2 adjacent frequencies)
*d BAEP = brainstem auditory evoked potentials, N = normal (wave latencies and interpeak latencies within normal limits),
_ = prolonged wave or interpeak latencies.
*e OAE = otoacoustic emissions.
na not available.
bilat bilateral.
lt left.
rt right.
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also had central eye movement dysfunction and
multiple white matter lesions on MRI. Absent waves
I in patient 6 were in keeping with severe cochlear
lesions.
TOAE were tested in 10 patients and ve had
abnormal ndings. This was the only abnormal
nding in patient 22, who complained of tinnitus.
In summary, 16 patients complained of auditory
symptoms, but in only 12 of these were audiological
abnormalities demonstrated. An additional two
asymptomatic patients also showed audiological
abnormalities. Ten patients revealed a bilateral
sensorineural hearing loss and further two patients
demonstrated a unilateral sensorineural hearing loss.
Ten patients had evidence of a cochlear lesion, one
patient had retrocochlear pathology and a further
patient demonstrated ndings compatible with a
mixed cochlear and retrocochlear lesion. Two
patients, with no previous history of middle ear
disease, had an unilateral conductive hearing loss
(patients 16 and 24) and were referred for further
otological investigation.
Vestibular testing
The results of vestibular testing are summarized in
Table III. Of the 26 patients with Behc¸et’s syndrome,
who underwent a quantitative vestibular assessment,
17 had symptoms which were suggestive of vestibular
dysfunction, such as dizziness, vertigo, disequili-
brium or oscillopsia, and in seven these symptoms
were a major complaint. Vestibular testing, however,
revealed abnormalities in only 10 patients. Smooth
pursuit gain was within normal limits in all patients.
Two patients (4 and 8) were deemed to demonstrate
TABLE III
quantitative vestibular and oculomotor assessment in patients with behc¸et’s syndrome
Patient
No.
Symptoms
*a
Nystagmus
*b
Pursuit
*c
OKN
*d
VOR
*e
VORS
*f
Caloric
Testing *g Conclusions
1 1 1 2 0.85 1.10 0.41 <0.05 N Normal
2 2 2 0.96 0.99 0.76 <0.05 N Normal
3 1 1 2 1.04 0.94 0.58 <0.05 N Normal
4 1 1 p 1.15
saccadic
lt 0.51
rt 0.29
0.50 <0.05 lt CP 13% Central and peripheral vestibular
dysfunction
lt 1.16
5 1 1 1 p 0.73 0.85 rt 0.86 <0.05 N Mild peripheral vestibular dysfunction
6 1 1 1 p 0.74 0.63 0.60 <0.05 na Mild peripheral vestibular dysfunction
7 1 1 2 0.76 1.02 0.54 <0.05 N Normal
8 1 1 2 0.71
saccadic
dysrhythmic
0.48
0.58 0.07 N Central eye movement dysfunction
9 1 1 1 2 0.6 0.72 0.66 <0.05 N Normal
10 1 1 2 na na na na N Normal
11 2 2 0.85 0.63 lt 0.61
rt 0.32
<0.05 lt CP 13% Mild peripheral vestibular dysfunction
12 1 2 na na na na N Normal
13 1 1 1 2 0.69 0.81 0 <0.05 Bilateral
CP 100%
Bilateral vestibular failure and mild
central oculomotor dysfunction
14 1 1 2 0.74 0.71 0.60 <0.05 rt CP 10% Mild peripheral vestibular dysfunction
15 2 2 1.02 1.01 0.64 <0.05 lt CP 100% Peripheral vestibular dysfunction
16 2 2 0.75 0.73 0.41 <0.05 N Normal
17 2 2 0.80 na 0.44 <0.05 N Normal
18 1 2 1.17 0.84 1.11 <0.05 N Normal
19 2 2 na na na na N Normal
20 2 2 0.76 0.81 0.56 <0.05 N Normal
21 1 1 1 p 0.93 0.65 0.16 <0.05 lt CP 100%
rt CP partial
Bilateral asymmetric vestibular lesion
22 1 2 0.73 0.82 0.42 <0.05 N Normal
23 2 2 0.72 0.68 0.80 <0.05 N Normal
24 1 1 1 2 0.74 0.61 0.64 <0.05 N Normal
25 1 1 1 2 0.71 0.68 0.44 <0.05 rt CP 10% Peripheral vestibular dysfunction
26 2 2 na na na na N Normal
Normal: >0.60 >0.60 >0.40 <0.05 CP<8%
DP<12%
*a 1 mild, 1 1 moderate, 1 1 1 severe, 2 absent.
*b p = nystagmus of peripheral type, c = nystagmus of central type, 2 = absent.
*c Gain of smooth pursuit, peak eye velocity/peak stimulus velocity at 0.2 Hz 30 deg.
*d Gain of optokinetic nystagmus: peak eye velocity/peak stimulus velocity at 40 deg/sec.
*e Gain of vestibuloocular reex: peak eye velocity/peak stimulus velocity of sinusoidal rotation at 0.2 Hz 30 deg/sec (patients 1,
28, 30 at 60 deg/sec).
*f Vestibuloocular nystagmus suppression by visual xation: peak eye velocity/peak stimulus velocity at sinusoidal rotation at
0.2 Hz 30 deg/sec.
*g Bithermal caloric testing by Fitzgerald-Hallpikemethod measuring duration f nystagmus. CP = canal paresis, DP = directional
preponderance.
na Not available
Numbers in bold indicate abnormal ndings.
lt left.
rt right.
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central visuo-vestibular dysfunction with saccadic
pursuit, low gain of OKN and a VORS abnormality
(patient 8). Patient 4 also demonstrated a peripheral
spontaneous nystagmus and a unilateral canal par-
esis on caloric testing. This patient was therefore
considered to demonstrate both peripheral and
central vestibular dysfunction. Three further patients
(5, 6 and 21) showed peripheral vestibular dysfunc-
tion, as judged by unidirectional, horizontal sponta-
neous nystagmus, with enhancement in the absence
of optic xation. Patients 5 and 21 also demonstrated
VOR abnormalities.
Five patients had a unilateral canal paresis on
caloric testing (patients 4, 11, 14, 15, and 25) and two
patients demonstrated bilateral vestibular dysfunc-
tion on caloric testing (patients 13 and 21). Patient 13
showed complete vestibular failure on both caloric
testing and sinusoidal VOR oscillation, while patient
21 had a subtotal loss on both tests.
In summary, nine patients with vestibular abnorm-
alities showed evidence of a peripheral vestibular
involvement, one of whom demonstrated additional
central vestibular dysfunction. One further patient
showed a mild central oculomotor abnormality. In
ve patients, the peripheral vestibular lesion was
unilateral and in two it was bilateral. Two additional
patients demonstrated spontaneous nystagmus of the
peripheral type and one of them showed also
directional preponderance on rotatory testing. In
the absence of any central oculomotor sings, these
ndings were interpreted to indicate a peripheral
vestibular lesion.
Discussion
In this study we have documented the type and
frequency of auditory and vestibular abnormalities
in Behc¸et’s syndrome. The lack of correlation
between other organ and audiovestibular involve-
ment is in keeping with the multifocal nature of the
disease process.1–3 A lack of correlation was also
found between the auditory and vestibular lesions,
but this may be explained by an understanding of the
vascular supply. The common cochlear artery and
the anterior vestibular artery are the main branches
of the labyrinthine artery and can be selectively
involved by immunologically mediated inamma-
tion. The cochlea, saccule and posterior canal are
supplied by the common cochlear artery, whereas
the utricle, together with the anterior and horizontal
canals, are supplied by the anterior vestibular
artery.20 Routine clinical vestibular tests allow
evaluation of only the horizontal semicircular canal
and, thus, a lesion of the anterior vestibular artery
will manifest as an isolated vestibular abnormality,
while involvement of the common cochlear artery
will give abnormalities on audiological testing.20
Although the aetiology and pathogenesis of
Behc¸et’s syndrome are unknown, there is evidence
supporting an important role for immunological
mechanisms. These include an association with
class I HLA B51 antigen, the presence of raised
circulating levels of cytokines, and the presence of g d
T lymphocytes reactive with peptides derived from
heat shock proteins.25–27 These ndings support the
hypothesis of an immunologically mediated vasculitis
in Behc¸et’s syndrome. Improvement of hearing
impairment in patients with this condition, in
response to immunomodulatory therapy has been
reported,28,29 and this provides additional evidence
that the inner ear lesions are immunologically
mediated.
An earlier report described 16 patients with
Behc¸et’s syndrome, 10 of whom demonstrated
inner ear involvement: ve of them with cochlear,
one with vestibular and four with auditory and
vestibular peripheral decits.7 Belkahia (1982),
reporting 16 patients with neuro-Behc¸et’s, found
eight with central vestibular damage, ve with
peripheral vestibular damage and two with hearing
loss.8 The 1991 study of Gemignani et al. revealed
cochlear hearing impairment in 12 patients out of 20
patients with Behc¸et’s syndrome. Five patients had
evidence of altered vestibular dysfunction, four of
the peripheral type. The authors concluded that
audiovestibular involvement in Behc¸et’s syndrome is
frequent and generally underestimated, the cochlea
being more frequently involved than the vestibular
labyrinth.9
The data obtained in our series are consistent with
these reports, although differences in patient selec-
tion hinder exact comparisons. Our series contains a
relatively large proportion (42 per cent) of patients
with neurological abnormalities and this may repre-
sent more aggressive or advanced pathology and,
thus, an increased prevalence of audiovestibular
involvement. Despite the high percentage of patients
with neurological involvement in this study, it is
interesting to note that almost all audiovestibular
abnormalities were of peripheral labyrinthine type,
indicating specic involvement of the labyrinth in
this condition and the relatively uncommon involve-
ment of the brainstem or cerebellum. However, the
slightly higher frequency of vestibular abnormalities
in our patients may reect the full battery of
vestibular investigations applied.
BAEPs were studied in 44 Behc¸et’s patients by
Stigby et al. Abnormalities were found in 52 per cent
of patients with neurological manifestations and in
31 per cent without. The abnormalities found
consisted of decreased amplitude of wave V, or
prolonged I–III or III–V interpeak latencies.30Rizzo
et al. reported a longitudinal multimodal evoked
potentials study in two patients with neuro-Behc¸et.
In one patient the BAEPs remained normal
throughout, while the other had absent BAEPs
attributed to a sensorineural hearing loss.31 Our
study showed BAEP abnormalities only in three
patients, in one of whom there was a severe cochlear
lesion and in another there was clear evidence of
widespread neurological involvement including cen-
tral eye movement dysfunction. The third patient
demonstrated no other audiovestibular abnormality.
Thus, BAEP alone would be an inappropriate test to
detect subclinical auditory lesions in Behc¸et patients,
particularly as the majority of patients in this study
labyrinthine involvement in behc¸et’s syndrome 527
had cochlear hearing loss. Characteristically, unless
the loss is profound, BAEPs are normal in cochlear
lesions.
Mild subclinical cochlear loss may be revealed
using TOAEs. In this study, ve out of 10 tested
patients showed abnormalities on TOAEs, and in
one patient this was the only abnormal audiological
nding. Moreover, four patients, who had been
evaluated prior to the introduction of routine TOAE
testing, had auditory complaints, but no audiological
decit was revealed. It is in this group that OAE
testing may be of greatest value for detecting
auditory abnormalities.
Overall, this study identies that auditory and/or
vestibular abnormalities were found in 73 per cent of
unselected group of Behc¸et’s syndrome, a preva-
lence equalling that of common symptoms in this
condition, including arthritis, gastrointestinal com-
plaints and neurological involvement.1,2 While we
not have an age-matched control population in this
study, we considered the control population of 40
normal subjects with an average age of 37.35 years
(SD 11.4) used in an earlier community study within
this unit.32 In this control group of similar age
distribution, the same audio-vestibular tests were
applied and we identied auditory abnormalities in
32.5 per cent and vestibular abnormalities in 20 per
cent. In view of similar demographics and identical
assessment methodology, we assume that the neuro-
otological abnormalities found in this group can be
used as a control for our study. Signicant difference
was found between the prevalence of audio-vestib-
ular abnormalities in Behc¸et’s patients versus control
(p = 0.003).
Little is known about inner ear involvement in
other systemic autoimmune disorders. Bowman
reported an eight per cent incidence of SNHL in
30 patients with systemic lupus erythematosus,33
while, in a controlled study by Andonopoulos, 57.5
per cent of 40 lupus erythematosus patients had
SNHL, without any correlation to disease activity or
system involvement.34 Similarly, in our study of
Behc¸et’s patients, the disease activity was not
correlated to audio-vestibular involvement. We
would, therefore, propose that the decision to treat
audio-vestibular symptoms in patients with other-
wise quiescent auto-immune disease should be taken
on clinical grounds. For example, rapidly worsening
cochlear symptoms would be treated aggressively,
whereas unilateral vestibular symptoms, which may
be expected to undergo central compensation, would
allow a more conservative approach.
SNHL has also been reported in rheumatoid
arthritis with a prevalence between 29 per cent to
48 per cent.35 In Wegener’s granulomatosis, hearing
loss has been reported to occur in 20–45 per cent of
patients, but the most common otological abnor-
mality was conductive hearing loss.36,37 While the
above studies concentrate on audiological ndings,
details of vestibular assessment in autoimmune
diseases are sparse or absent.
This study represents the largest study of audio-
vestibular investigations in unselected patients with
Behc¸et’s syndrome and the most detailed in terms of
neuro-otological investigation. Audiovestibular dys-
function is dened in approximately three-quarters
of patients with this disorder.
Since the diagnosis of Behc¸et’s syndrome is based
on the presence of the typical organ involvement,
identication of dysfunction in the auditory or
vestibular system, in the absence of any other
satisfactory explanation, may provide an additional
valuable clue in support of the diagnosis, particularly
in patients who do not fully meet the ISG criteria.
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